Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Smidt

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 27, 2020
MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variabilityR W Y Granzier, N M H Verbakel, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
TNM classification and the need for revision of pN3a breast cancerT J A van Nijnatten, M Moossdorff, L de Munck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2019
Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?M L G Vane, T J A van Nijnatten, P J Nelemans, et al.
International Journal of Colorectal Disease|April 27, 2017
Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0R Aarnoutse, J M P G M de Vos-Geelen, J Penders, et al.
European Journal of Radiology|November 16, 2016
Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patientsT J A van Nijnatten, E H Ploumen, R J Schipper, et al.
Scientific Reports|November 27, 2019
Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patientsS Samiei, T J A van Nijnatten, H C van Beek, et al.
Breast Cancer Research and Treatment|April 17, 2016
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapyL M van Roozendaal, B Goorts, M Klinkert, et al.
Scientific Reports|November 16, 2021
The diagnostic value of contrast-enhanced 2D mammography in everyday clinical useL M F H Neeter, H P J Raat, S D Meens-Koreman, et al.
European Radiology|April 22, 2016
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase studyU C Lalji, I P L Houben, R Prevos, et al.
Clinical Radiology|October 15, 2017
Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation studyT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 27, 2020
MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variabilityR W Y Granzier, N M H Verbakel, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
TNM classification and the need for revision of pN3a breast cancerT J A van Nijnatten, M Moossdorff, L de Munck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2019
Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?M L G Vane, T J A van Nijnatten, P J Nelemans, et al.
International Journal of Colorectal Disease|April 27, 2017
Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0R Aarnoutse, J M P G M de Vos-Geelen, J Penders, et al.
European Journal of Radiology|November 16, 2016
Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patientsT J A van Nijnatten, E H Ploumen, R J Schipper, et al.
Scientific Reports|November 27, 2019
Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patientsS Samiei, T J A van Nijnatten, H C van Beek, et al.
Breast Cancer Research and Treatment|April 17, 2016
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapyL M van Roozendaal, B Goorts, M Klinkert, et al.
Scientific Reports|November 16, 2021
The diagnostic value of contrast-enhanced 2D mammography in everyday clinical useL M F H Neeter, H P J Raat, S D Meens-Koreman, et al.
European Radiology|April 22, 2016
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase studyU C Lalji, I P L Houben, R Prevos, et al.
Clinical Radiology|October 15, 2017
Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation studyT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
Pageof 5